Enclomiphene (Trans-Clomiphene) Research in Kentucky | QSC

Enclomiphene (Trans-Clomiphene) Research — Kentucky

Enclomiphene (Trans-Clomiphene) is a Selective Oestrogen Receptor Modulator (SERM) — pure ER antagonist used in research models studying Pure Hypothalamic ER Antagonism, Secondary Hypogonadism — Isomer Comparison, Fertility-Preserving Testosterone Restoration. QSC supplies Enclomiphene to research institutions, university laboratories, and independent researchers across Kentucky with domestic USA shipping and third-party Janoshik COA verification.

About Enclomiphene (Trans-Clomiphene)

Enclomiphene is the trans-isomer of clomiphene citrate. Commercial clomiphene contains approximately 62% zuclomiphene (cis, weak ER agonist, long half-life) and 38% enclomiphene (trans, pure ER antagonist, shorter half-life). Enclomiphene as an isolated isomer provides pure hypothalamic ER blockade without the weak agonist activity of zuclomiphene. This results in cleaner LH/FSH stimulation, faste…

Full mechanistic overview and research data: Enclomiphene Research Hub →

QSC Shipping to Kentucky

QSC operates a domestic USA fulfilment network with 5-region shipping coverage. Orders to Kentucky ship from the nearest domestic hub — typically 3–5 business days. All compounds ship in sealed, temperature-appropriate, discrete packaging with Janoshik COA documentation.